{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:36Z","timestamp":1707525096654},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,4]]},"DOI":"10.7759\/cureus.39948","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T01:21:42Z","timestamp":1685928102000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case Report of a Patient With Prostate Adenocarcinoma Metastatic to the Posterior Peritoneum Despite the Negative Preoperative Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography\/Computed Tomography (PET\/CT) Scan"],"prefix":"10.7759","author":[{"given":"Celeste","family":"Shoeleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Graff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trushar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.4008","article-title":"Choline PET and PET\/CT in primary diagnosis and staging of prostate cancer","volume":"2","author":"Schwarzenb\u00f6ck S","year":"2012","unstructured":"Schwarzenb\u00f6ck S, Souvatzoglou M, Krause BJ. Choline PET and PET\/CT in primary diagnosis and staging of prostate cancer. Theranostics. 2012, 2:318-30. 10.7150\/thno.4008","journal-title":"Theranostics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medsci8030028","article-title":"Epidemiology, staging and management of prostate cancer","volume":"8","author":"Barsouk A","year":"2020","unstructured":"Barsouk A, Padala SA, Vakiti A, et al.. Epidemiology, staging and management of prostate cancer. Med Sci (Basel). 2020, 8:28. 10.3390\/medsci8030028","journal-title":"Med Sci (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00055","article-title":"Imaging for metastasis in prostate cancer: a review of the literature","volume":"10","author":"Turpin A","year":"2020","unstructured":"Turpin A, Girard E, Baillet C, et al.. Imaging for metastasis in prostate cancer: a review of the literature. Front Oncol. 2020, 10:55. 10.3389\/fonc.2020.00055","journal-title":"Front Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2324709620941313","article-title":"FDG-PET versus PSMA-PET: a patient with prostate cancer","volume":"8","author":"Kichloo A","year":"2020","unstructured":"Kichloo A, Amir R, Aljadah M, Wani F, Solanki S, Singh J, Chugh SS. FDG-PET versus PSMA-PET: a patient with prostate cancer. J Investig Med High Impact Case Rep. 2020, 8:2324709620941313. 10.1177\/2324709620941313","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.116.176859","article-title":"The role of 18F-sodium fluoride PET\/CT bone scans in the diagnosis of metastatic bone disease from breast and prostate cancer","volume":"44","author":"Kulshrestha RK","year":"2016","unstructured":"Kulshrestha RK, Vinjamuri S, England A, Nightingale J, Hogg P. The role of 18F-sodium fluoride PET\/CT bone scans in the diagnosis of metastatic bone disease from breast and prostate cancer. J Nucl Med Technol. 2016, 44:217-22. 10.2967\/jnmt.116.176859","journal-title":"J Nucl Med Technol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e586s","article-title":"Clinical perspectives of PSMA PET\/MRI for prostate cancer","volume":"73","author":"Barbosa FG","year":"2018","unstructured":"Barbosa FG, Queiroz MA, Nunes RF, Marin JF, Buchpiguel CA, Cerri GG. Clinical perspectives of PSMA PET\/MRI for prostate cancer. Clinics (Sao Paulo). 2018, 73:e586s. 10.6061\/clinics\/2018\/e586s","journal-title":"Clinics (Sao Paulo)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000799","article-title":"Prostate-specific membrane antigen PET\/computed tomography for staging prostate cancer","volume":"30","author":"Kumar ASR","year":"2020","unstructured":"Kumar ASR, Lawrentschuk N, Hofman MS. Prostate-specific membrane antigen PET\/computed tomography for staging prostate cancer. Curr Opin Urol. 2020, 30:628-34. 10.1097\/MOU.0000000000000799","journal-title":"Curr Opin Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2022.107653","article-title":"A young patient with prostatic carcinoma with testicular metastasis","volume":"99","author":"Balagobi B","year":"2022","unstructured":"Balagobi B, Gobishangar S, Sarma ST, Brammah RT, Jenil A. A young patient with prostatic carcinoma with testicular metastasis. Int J Surg Case Rep. 2022, 99:107653. 10.1016\/j.ijscr.2022.107653","journal-title":"Int J Surg Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: a population-based analysis","volume":"74","author":"Gandaglia G","year":"2014","unstructured":"Gandaglia G, Abdollah F, Schiffmann J, et al.. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014, 74:210-6. 10.1002\/pros.22742","journal-title":"Prostate"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215883","article-title":"Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: first-line imaging is afoot","volume":"548","author":"Jiao J","year":"2022","unstructured":"Jiao J, Zhang J, Li Z, et al.. Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: first-line imaging is afoot. Cancer Lett. 2022, 548:215883. 10.1016\/j.canlet.2022.215883","journal-title":"Cancer Lett"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000003802","article-title":"Detection of diffuse peritoneal and omental metastases from prostate cancer with 18F-PSMA-1007 PET\/CT","volume":"47","author":"Ji X","year":"2022","unstructured":"Ji X, Wang L, Lin J, Tang K. Detection of diffuse peritoneal and omental metastases from prostate cancer with 18F-PSMA-1007 PET\/CT. Clin Nucl Med. 2022, 47:e74-6. 10.1097\/RLU.0000000000003802","journal-title":"Clin Nucl Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001619","article-title":"A rare case of omentum invasive prostate cancer: staging with PSMA PET\/CT imaging and response to systemic therapy","volume":"42","author":"Ladwa R","year":"2017","unstructured":"Ladwa R, Gustafson S, McCaffrey E, Miles K, O'Byrne K. A rare case of omentum invasive prostate cancer: staging with PSMA PET\/CT imaging and response to systemic therapy. Clin Nucl Med. 2017, 42:e311-2. 10.1097\/RLU.0000000000001619","journal-title":"Clin Nucl Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004294","article-title":"Unusual metastatic prostate cancer in subcarinal lymph node and peritoneal nodule found on 18 F-PSMA PET\/CT with rising PSA of 0.4 ng\/mL","volume":"47","author":"Gao M","year":"2022","unstructured":"Gao M, Lu Y. Unusual metastatic prostate cancer in subcarinal lymph node and peritoneal nodule found on 18 F-PSMA PET\/CT with rising PSA of 0.4 ng\/mL. Clin Nucl Med. 2022, 47:989-90. 10.1097\/RLU.0000000000004294","journal-title":"Clin Nucl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000003414","article-title":"Rapidly evolving diffuse omental carcinomatosis of prostate cancer in 68Ga-PSMA PET\/CT","volume":"46","author":"Hober\u00fcck S","year":"2021","unstructured":"Hober\u00fcck S, Sommer U, Grey A, H\u00f6lscher T, Baretton GB, Kotzerke J. Rapidly evolving diffuse omental carcinomatosis of prostate cancer in 68Ga-PSMA PET\/CT. Clin Nucl Med. 2021, 46:e216-7. 10.1097\/RLU.0000000000003414","journal-title":"Clin Nucl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/146814-a-case-report-of-a-patient-with-prostate-adenocarcinoma-metastatic-to-the-posterior-peritoneum-despite-the-negative-preoperative-prostate-specific-membrane-antigen-psma-positron-emission-tomographycomputed-tomography-petct-scan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:27Z","timestamp":1707509127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/146814-a-case-report-of-a-patient-with-prostate-adenocarcinoma-metastatic-to-the-posterior-peritoneum-despite-the-negative-preoperative-prostate-specific-membrane-antigen-psma-positron-emission-tomographycomputed-tomography-petct-scan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,4]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.39948","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,4]]}}}